Wang X, Doherty G P, Leith M K, Curphey T J, Begleiter A
Manitoba Institute of Cell Biology, Manitoba Cancer Treatment and Research Foundation and Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Canada.
Br J Cancer. 1999 Jun;80(8):1223-30. doi: 10.1038/sj.bjc.6690489.
DT-diaphorase is a two-electron reducing enzyme that activates the bioreductive anti-tumour agent, mitomycin C (MMC). Cell lines having elevated levels of DT-diaphorase are generally more sensitive to MMC. We have shown that DT-diaphorase can be induced in human tumour cells by a number of compounds, including 1,2-dithiole-3-thione. In this study, we investigated whether induction of DT-diaphorase could enhance the cytotoxic activity of MMC in six human tumour cell lines representing four tumour types. DT-diaphorase was induced by many dietary inducers, including propyl gallate, dimethyl maleate, dimethyl fumarate and sulforaphane. The cytotoxicity of MMC was significantly increased in four tumour lines with the increase ranging from 1.4- to threefold. In contrast, MMC activity was not increased in SK-MEL-28 human melanoma cells and AGS human gastric cancer cells, cell lines that have high base levels of DT-diaphorase activity. Toxicity to normal human marrow cells was increased by 50% when MMC was combined with 1,2-dithiole-3-thione, but this increase was small in comparison with the threefold increase in cytotoxicity to tumour cells. This study demonstrates that induction of DT-diaphorase can increase the cytotoxic activity of MMC in human tumour cell lines, and suggests that it may be possible to use non-toxic inducers of DT-diaphorase to enhance the efficacy of bioreductive anti-tumour agents.
DT-黄递酶是一种双电子还原酶,可激活生物还原抗肿瘤药物丝裂霉素C(MMC)。DT-黄递酶水平升高的细胞系通常对MMC更敏感。我们已经表明,DT-黄递酶可被多种化合物诱导产生,包括1,2-二硫杂环戊烯-3-硫酮,在人肿瘤细胞中也能被诱导产生。在本研究中,我们调查了DT-黄递酶的诱导是否能增强MMC对代表四种肿瘤类型的六种人肿瘤细胞系的细胞毒活性。DT-黄递酶可被多种膳食诱导剂诱导产生,包括没食子酸丙酯、马来酸二甲酯、富马酸二甲酯和萝卜硫素。在四种肿瘤细胞系中,MMC的细胞毒性显著增加,增加幅度在1.4至3倍之间。相比之下,在DT-黄递酶活性基础水平较高的SK-MEL-28人黑色素瘤细胞和AGS人胃癌细胞系中,MMC活性并未增加。当MMC与1,2-二硫杂环戊烯-3-硫酮联合使用时,对正常人骨髓细胞的毒性增加了50%,但与对肿瘤细胞的细胞毒性增加三倍相比,这一增加幅度较小。本研究表明,DT-黄递酶的诱导可增加MMC在人肿瘤细胞系中的细胞毒活性,并表明使用无毒的DT-黄递酶诱导剂来增强生物还原抗肿瘤药物的疗效可能是可行的。